Beclu is an inhaled corticosteriod (beclometasone dipropionate) delivered via a pressurised metered dose inhaler (pMDI).1,2
Beclu 100 and 200 are branded generic alternatives to Clenil® Modulite® 100 and 200 indicated for the prophylactic management of mild, moderate, or severe asthma in adults or children.1,2
Beclu 200 is indicated in adult asthma only.2
Beclu offers NHS savings of up to £13 million per annum vs Clenil 100 and 200 pMDI list price3,4
Through carbon offsetting Beclu 100 and 200 pMDIs are certified as Carbon Neutral products.5,6
To read more about how carbon neutrality for Beclu is achieved, click here.
Beclu 100 and 200 pMDIs offer an NHS List Price saving of 30% vs Clenil 100 and 200 pMDI list price3
Prescribe Beclu by brandto release NHS savings
Beclometasone dipropionate pMDIs are listed as Category C medicines in the NHS Drug Tariff, therefore Beclu must be prescribed by brand to release savings for the NHS3
If you would like to know more about Beclu and the savings opportunities available, please get in touch by email to: UKRespiratory@lupin.com or call on: 01565 751378
